Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifuroxazide in Ulcerative Colitis
NCT05988528Phase 3Completed
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuroxazide in ulcerative colitis (UC). Started Aug 2023; status: completed.
02
Drugs
nifuroxazide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05988528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05988528.